Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis

[1]  J. Berry,et al.  Vitamin D deficiency, osteomalacia, and primary biliary cirrhosis , 1983, Digestive Diseases and Sciences.

[2]  J. Renner,et al.  Abnormal Bone Turnover in Cystic Fibrosis Adults , 2002, Osteoporosis International.

[3]  J. Wark,et al.  Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study. , 2001, The Journal of clinical endocrinology and metabolism.

[4]  S. Fowler,et al.  Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. , 2001, The Journal of clinical endocrinology and metabolism.

[5]  J. Adams,et al.  Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis , 2001, Thorax.

[6]  B. Hollis,et al.  Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. , 2001, The American journal of clinical nutrition.

[7]  J. Renner,et al.  Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. , 2000, American journal of respiratory and critical care medicine.

[8]  M. Kärkkäinen,et al.  Bone Mass and Markers of Bone and Calcium Metabolism in Postmenopausal Women Treated with 1,25-Dihydroxyvitamin D (Calcitriol) for Four Years , 2000, Calcified Tissue International.

[9]  J. C. Netelenbos,et al.  Strontium as a marker for intestinal calcium absorption: the stimulatory effect of calcitriol. , 2000, Clinical chemistry.

[10]  J. Adams,et al.  Low bone mineral density in adults with cystic fibrosis , 1999, Thorax.

[11]  G. Ardissino,et al.  No Difference in Intestinal Strontium Absorption After an Oral or an Intravenous 1,25(OH)2D3 bolus in Normal Subjects , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  R. Aris,et al.  Altered Calcium Homeostasis in Adults with Cystic Fibrosis , 1999, Osteoporosis International.

[13]  C. Haworth,et al.  Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis , 1998, The Lancet.

[14]  S. Ott,et al.  Osteoporosis in patients with cystic fibrosis. , 1998, Clinics in chest medicine.

[15]  R. Marcus,et al.  Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. , 1998, The Journal of pediatrics.

[16]  J. Renner,et al.  Increased Rate of Fractures and Severe Kyphosis: Sequelae of Living into Adulthood with Cystic Fibrosis , 1998, Annals of Internal Medicine.

[17]  R. Heaney,et al.  Calcium absorptive effects of vitamin D and its major metabolites. , 1997, The Journal of clinical endocrinology and metabolism.

[18]  H. DeLuca,et al.  Association Between Intestinal Vitamin D Receptor, Calcium Absorption, and Serum 1,25 Dihydroxyvitamin D in Normal Young and Elderly Women , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  H. van den Berg Bioavailability of vitamin D. , 1997, European journal of clinical nutrition.

[20]  W. Cohn Bioavailability of vitamin E. , 1997, European journal of clinical nutrition.

[21]  C. Madsen,et al.  Bone density in children and adolescents with cystic fibrosis. , 1996, The Journal of pediatrics.

[22]  B. Dawson-Hughes,et al.  Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. , 1995, The Journal of clinical endocrinology and metabolism.

[23]  H. Rasmussen,et al.  Calcium absorption responses to calcitriol in black and white premenopausal women. , 1995, The Journal of clinical endocrinology and metabolism.

[24]  G. Spears,et al.  Treatment of postmenopausal osteoporosis with calcitriol or calcium. , 1992, The New England journal of medicine.

[25]  J. Gallagher,et al.  Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study. , 1990, Annals of internal medicine.

[26]  J. Gallagher Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis. , 1990, Metabolism: clinical and experimental.

[27]  B. Riggs,et al.  Action of 1,25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate. , 1990, Metabolism: clinical and experimental.

[28]  M. Favus Intestinal calcium absorption: Have we absorbed enough from research to have a test for the patient? , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  S. Ott,et al.  Calcitriol treatment is not effective in postmenopausal osteoporosis. , 1989, Annals of internal medicine.

[30]  J. Aloia,et al.  Calcitriol in the treatment of postmenopausal osteoporosis. , 1988, The American journal of medicine.

[31]  I. Matheson,et al.  Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol. , 2009, Acta medica Scandinavica.

[32]  J. Bengoa,et al.  Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in chronic cholestatic liver disease. , 1987, The American journal of clinical nutrition.

[33]  R. Francis,et al.  Local action of oral 1,25-dihydroxycholecalciferol on calcium absorption in osteoporosis. , 1987, The American journal of clinical nutrition.

[34]  R. Recker,et al.  Estimation of true calcium absorption. , 1985, Annals of internal medicine.

[35]  M. McKenna,et al.  Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. , 1985, The Quarterly journal of medicine.

[36]  D. Marshall,et al.  A comparison of radioactive calcium absorption tests with net calcium absorption. , 1981, Clinical science.

[37]  C. Christiansen,et al.  Effect of 1,25‐dihydroxy ‐ vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis , 1981, European journal of clinical investigation.

[38]  J. Silver,et al.  Intestinal absorption of vitamin D sterols: differential absorption into lymph and portal blood in the rat. , 1981, Gastroenterology.

[39]  A. Merrett,et al.  Comparison of the appearance of radiolabelled vitamin D3 and 25-hydroxy-vitamin D3 in the chylomicron fraction of plasma after oral administration in man. , 1981, Clinical science.

[40]  A. Norman,et al.  Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure. , 1978, Metabolism: clinical and experimental.

[41]  S. Massry,et al.  Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man. , 1976, The Journal of clinical investigation.